Abstract:Objective: During Toll-like receptor 4 signaling, the Toll/interleukin-1 receptor domain is essential for interactions with downstream Toll/interleukin-1 receptor domain-containing adaptor proteins. The aim of this study is to investigate the role of the Toll/interleukin-1 receptor domain in the Toll-like receptor 4 signaling pathway during hepatic ischemia and reperfusion injury.Design: We genetically blocked the function of Toll/interleukin-1 receptor domain in mice and examined the effect on Toll-like receptor 4 signaling and the response to hepatic ischemia and reperfusion.Setting: University research laboratory.Subjects: Male BALB/c mice.Interventions: Male BALB/c mice were hydrodynamically administrated the target gene plasmid pTIR-IRES2-EGFP, empty vector containing enhanced green fluorescent protein, or normal saline. Animals underwent 90 minutes of partial hepatic ischemia, followed by 6 or 24 hours of reperfusion. Hepatic injury was assessed by measuring serum alanine transaminase, hepatic histology, and malondialdehyde. The expression of inflammatory cytokines and nuclear factor-B phosphorylation was examined in liver tissues. Hepatic apoptosis was evaluated by caspase-3 assays, terminal deoxynucleotidyl transferase-mediated deoxyuridinetriphosphate nick-end labeling staining, and the activation of Jun N-terminal kinase and p38 mitogen-activated protein kinase.Measurements and Main Results: Blocking the Toll/interleukin-1 receptor domain resulted in markedly lower serum alanine transaminase levels, reduced histologic injury, and lower malondialdehyde levels following 6 or 24 hours of hepatic reperfusion than mice receiving the vector alone or normal saline. Anti-Toll/interleukin-1 receptor treatment also reduced Toll-like receptor 4 expression and disrupted Toll/interleukin-1 receptor-Toll/interleukin-1 receptor interactions in Toll-like receptor 4 signaling pathways. Blocking the Toll/interleukin-1 receptor domain also prevented Toll-like receptor 4-mediated mitogen-activated protein kinase activation (via Jun N-terminal kinase and p38 mitogen-activated protein kinase), an activation that mediated liver ischemia and reperfusion injury via caspase-3 activation, resulting in increased hepatocellular apoptosis. Lastly, blocking the Toll/interleukin-1 receptor domain decreased inflammatory cytokine production by inhibiting nuclear factor-B activation.Conclusions: Toll/interleukin-1 receptor domain inhibition disrupts the interaction of Toll-like receptor 4 with its adaptor proteins, which abrogates downstream signaling pathways and prevents the activation of nuclear factor-B and Jun N-terminal kinase/p38. This reduction in signaling consequently reduces hepatic inflammation, cell apoptosis, and hepatic damage. Toll/interleukin-1 receptor domain-targeted therapy thus represents a new approach to inhibit the intracellular Toll-like receptor 4 signaling pathway and reveals novel therapeutic target sites, which will facilitate the development of specific therapeutic agents.

Co-Blocking Tlr and Cd154 Leads Profound Protection Against Renal Ischemia-Reperfusion Injury in Mice

Pharmacological Inhibition Of Myd88 Homodimerization Counteracts Renal Ischemia Reperfusion-Induced Progressive Renal Injury In Vivo And In Vitro

Powerful Protection Against Renal Ischemia Reperfusion Injury by T Cell-Specific NF-κB Inhibition.

A Cell-Penetrating Peptide That Blocks Toll-Like Receptor Signaling Protects Kidneys against Ischemia-Reperfusion Injury

Protective effect of indomethacin in renal ischemia-reperfusion injury in mice.

Role of Regulatory T Cells in Renal Ischemia-Reperfusion Injury in Mice

Protection of Kidney by Ischemic Postconditioning Through Inhibition of TLR4/NF-κB Pathway

Protective Effect of CD4+CD25highCD127low Regulatory T Cells in Renal Ischemia–reperfusion Injury

Protective effect and mechanisms of penotoxifylline on ischemia-reperfusion injury in rat kidneys

[High STING expression exacerbates renal ischemia-reperfusion injury in mice by regulating the TLR4/NF-κB/NLRP3 pathway and promoting inflammation and apoptosis]

Ischemic postconditioning ameliorates acute kidney injury induced by limb ischemia/reperfusion via transforming TLR4 and NF-κB signaling in rats

Protective Effect of CXCR3

The role of Toll-like receptor (TLR) 2 and 9 in renal ischemia and reperfusion injury

Inhibiting the Toll-Like Receptor 4 Toll/interleukin-1 Receptor Domain Protects Against Hepatic Warm Ischemia and Reperfusion Injury in Mice.

Protective Effect of CXCR3⁺CD4⁺CD25⁺Foxp3⁺ Regulatory T Cells in Renal Ischemia-Reperfusion Injury.

Overexpression of stanniocalcin-1 inhibits reactive oxygen species and renal ischemia/reperfusion injury in mice

Superagonistic CD28 Protects Against Renal Ischemic Injury by Expansion of Regulatory T-Cell.

Small interfering RNA targeting TNF-α gene significantly attenuates renal ischemia-reperfusion injury in mice

412.10: Blocking of the CD40-CD154 Pathway Inhibits Macrophage Infiltration and Reduces Fibrosis After Renal Transplantation

DOUBLE DEFICIENCY OF C5AR/C3AR SIGNIFICANTLY PREVENTS MICE FROM RENAL ISCHEMIA/REPERFUSION INJURY: 1790

Pathophysiologic Role of T Lymphocytes in Renal Ischemia-Reperfusion Injury in Mice